Orf virus infection and host immunity

Current Opinion in Infectious Diseases

Volumn 19, Issue 2, 2006, Pages 127-131

  Haig, David M ^a  

^a MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Immunomodulation; Orf; Orf virus; Ovine skin; Parapoxvirus

Indexed keywords

CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VASCULOTROPIN A; VIRULENCE FACTOR; VIRUS VECTOR; VIRUS PROTEIN;

ANTIGEN EXPRESSION; GENE SEQUENCE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOMODULATION; MOLECULAR GENETICS; NONHUMAN; PARAPOXVIRUS; POXVIRUS; REVIEW; SHEEP; SKIN INFECTION; STRUCTURE ACTIVITY RELATION; VIRUS CELL INTERACTION; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS INFECTION; VIRUS PATHOGENESIS; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; SHEEP DISEASE; SKIN; VIROLOGY; VIRULENCE;

ANIMALS; ECTHYMA, CONTAGIOUS; ORF VIRUS; SHEEP; SKIN; VIRAL PROTEINS; VIRULENCE;

EID: 33745005509     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qco.0000216622.75326.ef     Document Type: Review

References (39)

1. Haig DM, Mercer AA. Orf. Vet Res 1998; 29:311-326.
2. Thomas K, Tompkins DM, Sainsbury AW, et al. A novel poxvirus lethal to red squirrels (Sciurus vulgaris). J Gen Virol 2003; 84:3337-3341.
3. Dashtseren T, Solovyev B, Varejka F, Khokhoo A. Camel contagious ecthyma (pustular dermatitis). Acta Virol 1984; 28:122-127.
4. Clark C, McIntyre PG, Evans A, et al. Human sealpox resulting from a seal bite: confirmation that sealpox virus is zoonotic. Br J Dermatol 2005; 152:791-793.
5. Tikkanen MK, McInnes CJ, Mercer AA, et al. Recent isolates of parapoxvirus of Finnish reindeer (Rangifer tarandus tarandus) are closely-related to bovine pseudocowpox virus. J Gen Virol 2004; 85:1413-1418.
6. Anderson I, Reid HW, Nettleton PF, et al. Detection of cellular cytokine mRNA expression during orf virus infection in sheep: differential IFN-γ mRNA expression by cells in primary versus reinfection skin lesions. Vet Immunol Immunopathol 2001; 83:161-176.
7. Haig DM. Subversion and piracy: DNA viruses and immune evasion. Res Vet Sci 2001; 70:205-219.
8. Delhon G, Tulman ER, Afonso CL, et al. Genomes of the parapoxviruses orf virus and bovine papular stomatitis virus. J Virol 2004; 78:168-177. Genome sequence of two PPVs allowing molecular characterization of PPV and an insight into possible mechanisms of pathogenesis.
9. Wood AR, McInnes CJ. Transcript mapping of the 'early' genes of orf virus. J Gen Virol 2003; 84:2993-2998.
10. McInnes CJ,Wood AR, Mercer AA. Orf virus encodes a homolog of the vaccinia virus interferon-resistance gene E3L. Virus Genes 1998; 17:107-115.
11. Haig DM, McInnes CJ, Thomson J, et al. The orf virus gene OV20.0L gene product is involved in interferon resistance and inhibits interferon-inducible, double-stranded RNA-dependent kinase. Immunology 1998; 93:335-340.
12. Brandt TA, Jacobs BL. Both carboxy- and amino-terminal domains of the vaccinia virus interferon-resistance gene E3L are required for pathogenesis in a mouse model. J Virol 2001; 75:850-862.
13. Vijaysri S, Talasela L, Mercer A, et al. The orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo. Virology 2003; 314:305-314.
14. Seet B, McCaughan CA, Handel T, et al. Analysis of an orf virus chemokine-binding protein: shifting ligand specificities among a family of poxvirus viroceptors. Proc Natl Acad Sci USA 2003; 100:15137-15142.
15. Yoshida T, Imai T, Kakizaki M, et al. Identification of single C motif-1/lymphotactin receptor XCR1. J Biol Chem 1998; 273:16551-16554.
16. Deane D, McInnes CJ, Percival A, et al. Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. J Virol 2000; 74:1313-1320.
17. McInnes CJ, Deane DL, Haig DM, et al. Glycosylation, disulphide bond formation and the presence of a WSXWS-like motif in the orf virus GIF protein are critical for maintaining the integrity of binding to ovine granulocyte-macrophage colony-stimulating factor and interleukin-2. J Virol 2005; 79:11205-11213. Evidence that the GIF protein has structure-function features in common with type 1 cytokine receptors in spite of no apparent primary amino acid similarity of these receptors.
18. Doshi PD, DiPersio JF. Three conserved motifs in the extracellular domain of the human granulocyte-macrophage colony-stimulating factor receptor subunit are essential for ligand binding and surface expression. Blood 1994; 84:2539-2553.
19. Seet BT, Barrett J, Robichaud J, et al. Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor, M-T1. J Biol Chem 2001; 276:30504-30513.
20. Ng A, Tscharke DC, Reading PC, Smith GL. The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. J Gen Virol 2001; 82:2095-2105.
21. Haig DM, Thomson J, McInnes CJ, et al. A comparison of the anti-inflammatory and immuno-stimulatory activities of orf virus and ovine interleukin-10. Virus Res 2002; 90:303-316.
22. Lateef Z, Fleming S, Halliday G, et al. Orf virus-encoded interleukin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells. J Gen Virol 2003; 84:1101-1109.
23. Lyttle DJ, Fraser KM, Fleming SB, et al. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol 1994; 68:64-92.
24. Wise L, Veikkola T, Mercer A, et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA 1999; 96:3071-3076.
25. Meyer M, Clauss M, Lepple-Wienhues A, et al. A novel vascular endothelial growth factor encoded by orf virus, VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor kinase. EMBO J 1999; 18:363-374.
26. Savory LJ, Stacker SA, Fleming SB, et al. Viral vascular endothelial growth factor plays a critical role in orf virus infection. J Virol 2000; 74:10699-10706.
27. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardivasc Res 2005; 65:550-563.
28. Mercer AA, Wise LM, Scagliarini A, et al. Vascular endothelial growth factors encoded by orf virus show surprising sequence variation but have a conserved, functionally-relevant structure. J Gen Virol 2002; 83:2845-2855.
29. Kiba A, Sagara H, Hara T, Shibuya M. VEGFR-2-specific ligand VEGF-E induces a non-edematous hyper-vascularisation in mice. Biochem Biophys Res Comm 2003; 301:371-377.
30. Shibuya M. Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E. Cancer Sci 2003; 94:751-756.
31. Gabrilovitch DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996; 2:1096-1098.
32. Dikov MM, Ohm JE, Ray N, et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J Immunol 2005; 174:215-222.
33. Lear A, Hutchison G, Reid HW, et al. Phenotypic characterisation of the dendritic cells accumulating in the ovine dermis following primary and secondary orf virus infections. Eur J Dermatol 1996; 6:135-140.
34. Riboldi E, Musso T, Moroni E, et al. Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J Immunol 2005; 175:2788-2792.
35. Scagliarini A, Gallina L, Dal Poxxo F, et al. Heparin-binding activity of orf virus F1L protein. Virus Res 2004; 105:107-112.
36. Fischer T, Planz O, Stitz L, Rziha H-J. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J Virol 2003; 77:9312-9323.
37. Henkel M, Planz O, Fischer T, et al. Prevention of virus persistence and protection against immunopathology after borna disease virus infection of the brain by a novel orf virus recombinant. J Virol 2005; 79:314-325. A good example of the effectiveness of orf virus as a vector expressing Borna disease virus antigen to prevent virus pathogenesis and disease.
38. Weber O, Siegling A, Friebe A, et al. Inactivated parapoxvirus ovis (orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. J Gen Virol 2003; 84:1843-1852.
39. Friebe A, Siegling A, Friederichs S, et al. Immunomodulatory effects of inactivated parapoxvirus ovis (orf virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J Virol 2004; 78:9400-9411. A description of the underlying mechanism of the immuno-modulatory activity of the inactivated orf virus particles acting on macrophages or dendrite cells and inducing a Th1 response subsequently controlled by an IL-10 response.